IBDEI1UU ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32652,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,32652,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,32653,0)
 ;;=D63.0^^182^1992^22
 ;;^UTILITY(U,$J,358.3,32653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32653,1,3,0)
 ;;=3^Anemia in Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,32653,1,4,0)
 ;;=4^D63.0
 ;;^UTILITY(U,$J,358.3,32653,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,32654,0)
 ;;=D63.8^^182^1992^20
 ;;^UTILITY(U,$J,358.3,32654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32654,1,3,0)
 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,32654,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,32654,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,32655,0)
 ;;=C22.3^^182^1992^23
 ;;^UTILITY(U,$J,358.3,32655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32655,1,3,0)
 ;;=3^Angiosarcoma of Liver
 ;;^UTILITY(U,$J,358.3,32655,1,4,0)
 ;;=4^C22.3
 ;;^UTILITY(U,$J,358.3,32655,2)
 ;;=^5000936
 ;;^UTILITY(U,$J,358.3,32656,0)
 ;;=D61.9^^182^1992^24
 ;;^UTILITY(U,$J,358.3,32656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32656,1,3,0)
 ;;=3^Aplastic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,32656,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,32656,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,32657,0)
 ;;=D56.1^^182^1992^26
 ;;^UTILITY(U,$J,358.3,32657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32657,1,3,0)
 ;;=3^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,32657,1,4,0)
 ;;=4^D56.1
 ;;^UTILITY(U,$J,358.3,32657,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,32658,0)
 ;;=C83.79^^182^1992^27
 ;;^UTILITY(U,$J,358.3,32658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32658,1,3,0)
 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,32658,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,32658,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,32659,0)
 ;;=C83.70^^182^1992^28
 ;;^UTILITY(U,$J,358.3,32659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32659,1,3,0)
 ;;=3^Burkitt Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,32659,1,4,0)
 ;;=4^C83.70
 ;;^UTILITY(U,$J,358.3,32659,2)
 ;;=^5001591
 ;;^UTILITY(U,$J,358.3,32660,0)
 ;;=D09.0^^182^1992^35
 ;;^UTILITY(U,$J,358.3,32660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32660,1,3,0)
 ;;=3^Carcinoma in Situ of Bladder
 ;;^UTILITY(U,$J,358.3,32660,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,32660,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,32661,0)
 ;;=D06.9^^182^1992^36
 ;;^UTILITY(U,$J,358.3,32661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32661,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix
 ;;^UTILITY(U,$J,358.3,32661,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,32661,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,32662,0)
 ;;=D06.0^^182^1992^38
 ;;^UTILITY(U,$J,358.3,32662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32662,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,32662,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,32662,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,32663,0)
 ;;=D06.1^^182^1992^39
 ;;^UTILITY(U,$J,358.3,32663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32663,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,32663,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,32663,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,32664,0)
 ;;=D06.7^^182^1992^37
 ;;^UTILITY(U,$J,358.3,32664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32664,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Other Parts
 ;;^UTILITY(U,$J,358.3,32664,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,32664,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,32665,0)
 ;;=D04.9^^182^1992^40
 ;;^UTILITY(U,$J,358.3,32665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32665,1,3,0)
 ;;=3^Carcinoma in Situ of Skin
 ;;^UTILITY(U,$J,358.3,32665,1,4,0)
 ;;=4^D04.9
 ;;
 ;;$END ROU IBDEI1UU
